Pharma Focus Asia

InDevR and Sino Biological Join Forces to Provide Advanced Multiplexed Analytical Solutions for mRNA Vaccines and Cell & Gene Therapies

Thursday, June 06, 2024

InDevR, Inc., a leading provider of analytical tools for vaccine quality control and testing, has teamed up with Sino Biological, Inc., a biotechnological firm listed on the Shenzhen stock exchange (SZSE: 301047), which specializes in biological research reagents and related technical services. This partnership aims to speed up the development of multiplex assays for a variety of applications in vaccine production, mRNA therapies, and cell and gene therapy.

As part of the collaboration, Sino Biological’s comprehensive range of high-quality antibodies, antigens, and other reagents will be made available for use on InDevR’s VaxArray Platform. This platform is widely used by biopharmaceutical companies globally for its ability to perform multiplex assays, which help simplify, standardize, and accelerate the development, optimization, and scaling of new vaccine formulations. The alliance intends to develop advanced analytical tools to support breakthroughs in mRNA vaccine technology, vaccine development, and the fast-growing field of cell and gene therapy.

Since its inception in 2003, InDevR has been dedicated to creating innovative analytical solutions for the vaccine industry. “We aim to leverage our expertise to address the critical need for better analytical tools in the realms of cell and gene therapies and mRNA vaccine testing,” stated Dr. Kathy Rowlen, CEO of InDevR. “Our partnership with Sino Biological, known for their extensive range of high-quality products, will drive new product development and enable our customers to easily design their own multiplex assays.”

Sino Biological, recognized for its expertise in recombinant protein production and antibody development, is enthusiastic about this collaboration. “We are excited to work with InDevR to enhance the capabilities of their VaxArray Platform,” said Dr. Rob Burgess, Chief Business Officer at Sino Biological. “By integrating our extensive range of quality reagents with InDevR’s advanced analytical technologies, we aim to deliver superior solutions for in-process and quality control testing in the biopharmaceutical industry.”

 

Soyrce: indevr.com

magazine-slider-image
magazine-slider-image
Cytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024